Home › Glioblastoma › Nebraska
Glioblastoma clinical trials in Nebraska
5 studies for Glioblastoma are looking for participants at sites in Nebraska.
Cities in Nebraska
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- University of Nebraska Medical Center, Omaha
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07326566A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
- University of Nebraska Medical Center, Omaha
RecruitingPhase 1
Ages 19 and older · All sexes · Updated Sep 14, 2026 · NCT05698524Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Nebraska Cancer Specialists (Midwest Cancer Center - Legacy), Omaha
- XCancer Omaha / Urology Cancer Center, Omaha
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT05283330Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
- University of Nebraska Medical Center, Omaha
RecruitingPhase 1/2
Ages 19 and older · All sexes · Updated Jun 8, 2026 · NCT06011109SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Omaha
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.